{"organizations": [], "uuid": "a25e8fe778b52436f1757cd815d7d16ab1f4a43b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-amphastar-pharmaceuticals-reports/brief-amphastar-pharmaceuticals-reports-q4-gaap-earnings-per-share-0-03-idUSASC09RUX", "country": "US", "domain_rank": 408, "title": "BRIEF-Amphastar Pharmaceuticals Reports Q4 Gaap Earnings Per Share $0.03", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T22:10:00.000+02:00", "replies_count": 0, "uuid": "a25e8fe778b52436f1757cd815d7d16ab1f4a43b"}, "author": "", "url": "https://www.reuters.com/article/brief-amphastar-pharmaceuticals-reports/brief-amphastar-pharmaceuticals-reports-q4-gaap-earnings-per-share-0-03-idUSASC09RUX", "ord_in_thread": 0, "title": "BRIEF-Amphastar Pharmaceuticals Reports Q4 Gaap Earnings Per Share $0.03", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-amphastar pharmaceuticals reports", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "amphastar pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12, 2018 / 8:11 PM / Updated 8 minutes ago BRIEF-Amphastar Pharmaceuticals Reports Q4 Gaap Earnings Per Share $0.03 Reuters Staff 1 Min Read March 12 (Reuters) - Amphastar Pharmaceuticals Inc: * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS AND FISCAL YEAR ENDED DECEMBER 31, 2017 * Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.38 * Q4 GAAP EARNINGS PER SHARE $0.03 * Q4 REVENUE $60.4 MILLION VERSUS I/B/E/S VIEW $60.6 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.02 â€” THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-12T22:10:00.000+02:00", "crawled": "2018-03-12T22:28:32.003+02:00", "highlightTitle": ""}